| Identification and characterization of metabolically benign obesity in humans N Stefan, K Kantartzis, J Machann, F Schick, C Thamer, K Rittig, ... Archives of internal medicine 168 (15), 1609-1616, 2008 | 1346 | 2008 |
| Diabetes-associated sustained activation of the transcription factor nuclear factor-κB A Bierhaus, S Schiekofer, M Schwaninger, M Andrassy, PM Humpert, ... Diabetes 50 (12), 2792-2808, 2001 | 1145 | 2001 |
| Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach A Floegel, N Stefan, Z Yu, K Mühlenbruch, D Drogan, HG Joost, A Fritsche, ... Diabetes 62 (2), 639-648, 2013 | 1052 | 2013 |
| Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications N Stefan, HU Häring, FB Hu, MB Schulze The lancet Diabetes & endocrinology 1 (2), 152-162, 2013 | 932 | 2013 |
| Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism O Tschritter, A Fritsche, C Thamer, M Haap, F Shirkavand, S Rahe, ... Diabetes 52 (2), 239-243, 2003 | 862 | 2003 |
| T-helper-1-cell cytokines drive cancer into senescence H Braumüller, T Wieder, E Brenner, S Aßmann, M Hahn, M Alkhaled, ... Nature 494 (7437), 361-365, 2013 | 833 | 2013 |
| Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies N Stefan, HU Häring, K Cusi The lancet Diabetes & endocrinology 7 (4), 313-324, 2019 | 831 | 2019 |
| Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. S Jacob, J Machann, K Rett, K Brechtel, A Volk, W Renn, E Maerker, ... Diabetes 48 (5), 1113-1119, 1999 | 786 | 1999 |
| Causes and metabolic consequences of fatty liver N Stefan, K Kantartzis, HU Häring Endocrine reviews 29 (7), 939-960, 2008 | 740 | 2008 |
| α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans N Stefan, AM Hennige, H Staiger, J Machann, F Schick, SM Kröber, ... Diabetes care 29 (4), 853-857, 2006 | 725 | 2006 |
| Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance BM Balletshofer, K Rittig, MD Enderle, A Volk, E Maerker, S Jacob, ... Circulation 101 (15), 1780-1784, 2000 | 723 | 2000 |
| Pathophysiology and pharmacological treatment of insulin resistance S Matthaei, M Stumvoll, M Kellerer, HU Häring Endocrine reviews 21 (6), 585-618, 2000 | 710 | 2000 |
| Association of the TG polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes M Stumvoll, O Tschritter, A Fritsche, H Staiger, W Renn, M Weisser, ... Diabetes 51 (1), 37-41, 2002 | 633 | 2002 |
| The role of hepatokines in metabolism N Stefan, HU Häring Nature Reviews Endocrinology 9 (3), 144-152, 2013 | 617 | 2013 |
| Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. M Kasuga, Y Zick, DL Blith, FA Karlsson, HU Häring, CR Kahn Journal of Biological Chemistry 257 (17), 9891-9894, 1982 | 564 | 1982 |
| An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes MB Schulze, K Hoffmann, H Boeing, J Linseisen, S Rohrmann, M Mohlig, ... Diabetes care 30 (3), 510-515, 2007 | 562 | 2007 |
| Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans N Stefan, F Schick, HU Häring Cell metabolism 26 (2), 292-300, 2017 | 545 | 2017 |
| Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans S Kullmann, M Heni, M Hallschmid, A Fritsche, H Preissl, HU Häring Physiological reviews, 2016 | 543 | 2016 |
| Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: a randomized … A Fritsche, MA Schweitzer, HU Hring, 4001 Study Group* Annals of internal medicine 138 (12), 952-959, 2003 | 527 | 2003 |
| The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism M Stumvoll, H Haring Diabetes 51 (8), 2341-2347, 2002 | 523 | 2002 |
